BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Abliva - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://abliva.com
X-WR-CALDESC:Händelser för Abliva
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220222
DTEND;VALUE=DATE:20220225
DTSTAMP:20260430T164707
CREATED:20211129T085909Z
LAST-MODIFIED:20211129T085909Z
UID:2992-1645488000-1645747199@abliva.com
SUMMARY:Mitochondria-Targeted Drug Development Summit
DESCRIPTION:Abliva kommer att delta och presentera vid konferensen Mitochondria-Targeted Drug Development Summit i Boston\, MA\, USA. Eventet hålls den 22 – 24 februari 2022. \nVD Ellen Donnelly kommer att presentera under sessionen Patient-Focused Drug Development for Mitochondrial Disease. \nSynopsis: \n\nHighlighting the impact of patient input on research and development at Abliva\nProviding an overview of the multiple therapeutic options for mitochondrial disease being pursued at Abliva\nPresenting placebo controlled PMD patient data from our lead asset\, KL1333
URL:https://abliva.com/sv/event/mitochondria-targeted-drug-development-summit-2/
LOCATION:Hyatt Regency Boston/Cambridge\, 575 Memorial Dr\, Cambridge\, Massachusetts\, 02139\, United States
CATEGORIES:Vetenskapligt event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20211130
DTEND;VALUE=DATE:20211203
DTSTAMP:20260430T164707
CREATED:20211111T130848Z
LAST-MODIFIED:20211122T145613Z
UID:2972-1638230400-1638489599@abliva.com
SUMMARY:Mitochondrial Medicine - Therapeutic Development
DESCRIPTION:Abliva kommer att delta vid den virtuella konferensen Mitochondrial Medicine – Therapeutic Development\, arrangerad av Wellcome Connecting Science vid Wellcome Genome Campus i Storbritannien. Konferensen äger rum den 30 nov – 2 dec 2021. \nAblivas medicinska chef Magnus Hansson\, har blivit inbjuden att hålla en presentation i ämnet Academia-pharma interplay in drug development\, under Session 1: Mitochondrial Medicine – pharma and funding perspectives.
URL:https://abliva.com/sv/event/mitochondrial-medicine-therapeutic-development-2/
LOCATION:Virtual
CATEGORIES:Vetenskapligt event
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210624
DTEND;VALUE=DATE:20210627
DTSTAMP:20260430T164707
CREATED:20210524T105444Z
LAST-MODIFIED:20210524T105444Z
UID:2778-1624492800-1624751999@abliva.com
SUMMARY:UMDF Mitochondrial Medicine
DESCRIPTION:Den amerikanska patientorganisationen United Mitochondrial Disease Foundation (UMDF) arrangerar sitt årliga Mitochondrial Medicine Symposium\, i år virtuellt\, i juni.  \nAbliva kommer att delta i de vetenskapliga delarna av symposiet: \n\nMagnus Hansson\, medicinsk chef\, kommer att utgöra en av paneldeltagarna fredagen den 25 juni klockan 13.50 EST\, i Clinical Trials Panel #2 Discussion\, tillsammans med representanter från Baylor College of Medicine\, Cyclerion Therapeutics och Khondrion.\nData från Ablivas fas 1a/b-studie med KL1333 kommer att presenteras på en vetenskaplig e-Poster\, tillgänglig för registrerade deltagare under hela evenemanget.
URL:https://abliva.com/sv/event/umdf-mitochondrial-medicine-2/
LOCATION:Virtual
CATEGORIES:Vetenskapligt event
END:VEVENT
END:VCALENDAR